Publications - continued

(51) Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and reliability of patient selected goals as an outcome measure in Overactive Bladder. Int Urogynecol J Pelvic Floor Dysfunct 2011; 22(7): 841-847

(52) Huwyler M, Latthe P, Parsons M, Burton C, Renganathan A, Robinson D, Cardozo L, Toozs-Hobson P. Retrospective case modelling to assess the impact of early intervention of voiding dysfunction after retropubic tape. When is it best to intervene? Int Urogynaecol J Pelvic Floor Dysfunct. 2010; 21(7): 823-827

(53) Kuhn A, Bank S, Robinson D, Klimek M, Kuhn P, Raio L. How should bladder wall thickness be measured? A comparison of vaginal, perineal and abdominal ultrasound. Neurourol Urodyn 2010; 29(8): 1393-1396

(54) Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement for women with urogenital prolapse. Int Urogynaecol J Pelvic Floor Dysfunct. 2010; 21(5): 523-528.

(55) Robinson D, Jacklin P, Cardozo L. Is Cost the Achilles Heal of Posterior Tibial Nerve Stimulation: A Cost Minimisation Comparison with Antimuscarinic Therapy. Neurourol Urodyn 2009; 28: 879-881.

(56) Cartwright R, Cox P, Cardozo L, Srikrishna S, Robinson D. Screening Tools for Voiding Difficulties in Women: A Comparison of the ICIQ-FLUTS and the modified IPSS Questionnaires. Neurourol Urodyn 2009; 28:652-653.

(57) Thiagamoorthy G, Khalil A, Leslie G, Srikrishna S, Robinson D, Cardozo L. Should we pack it in? A prospective randomised double blind study assessing the effect of Vaginal Packing in Pelvic Floor Surgery. Neurourol Urodyn 2010; 29(6): 805-1255.

(58) Robinson D, Jacklin P, Cardozo L. What’s Needling us about the management of Refractory Overactive Bladder? An economic analysis of the use of Percutaneous Nerve Stimulation and Botulinum Toxin. Neurourol Urodyn 2010; 29(6): 805-1255.

(59) Van Kerrebroeck PE, Dmochowski R, FitzGerald MP, Hashim H, Norgaard JP, Robinson D, Weiss JP. Nocturia Research: Current Status and Future Perspectives. Neurourol Urodyn 2010; 29(4): 623-628.

(60) Srikrishna S, Robinson D, Cardozo L. Ringing the changes in teh evaluation of Urogenital Prolapse. Neurourol Urodyn 2010; 29(6): 805-1255.

(61) Srikrishna S, Robinson D, Cardozo L, Gonzalez J. Can Sex Survive Pelvic Floor Surgery? Int Urogynaecol J Pelvic Floor Dysfunct 2010: 21(11): 1313-1319.

(62) Cartwright R, Srikrishna S, Cardozo L, Robinson D. Patient selected goals in Overactive Bladder: A placebo contolled randomised double blind trial of Transdermal Oxybutynin for the treatment of urgency and urge incontinence. BJU Int 2011; 107(1): 70-76.

(63) Srikrishna S, Robinson D, Cardozo L. Ringing the changes in the evaluation of Urogenital Prolapse. Int Urogynaecol J Pelvic Floor Dysfunct 2011; 22(2): 171-175.

(64) Srikrishna S, Robinson D, Cardozo L. A longitudinal study of patient and surgeon goal achievement 2 years after surgery following pelvic floor dysfunction surgery. BJOG 2010; 117(12): 1504-1511.

(65) Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and Reliability of the Patient’s Perception of Intensity of Urgency Scale in Overactive Bladder. BJU Int 2011; 107(10): 1612-1617.

(66) Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and reliability of Patient Selected Goals as an Outcome Measure in Overactive Bladder. Int Urogynaecol J Pelvic Floor Dysfunct 2011; 22(7): 841-847.

(67) Sturdee D, Pines A; International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, Birkhauser MH, Brincat M, Cardozo L, de Villiers TJ, Gambacciani M, Gompel AA, Henderson VW, Kluft C, Lobo RA, MacLennan AH, Marsden J, Nappi RE, Panay N, Pickar JH, Robinson D, Simon J, Sitruk-Ware RL, Stevenson JC. Updated IMS recommendations on postmenopausal hormone therapy and preventive stratergies for midlife health. Climacteric 2011; 14(3): 302-320.

(68) Bosch R, Cardozo L, Hashim H, Hilton P, Oelke M, Robinson D. Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol Urodyn 2011; 30(5): 735-740.

(69) Robinson D, Cardozo L. Oestrogen and the Lower Urinary Tract. Neurourol Urodyn 2011; 30(5): 754-757.

(70) Hilton P, Robinson D. Defining Cure. Neurourol Urodyn 2011; 30(5):741-745.

(71) Kuhn A, Genoud S, Robinson D, Herrmann G, Gunthert A, Brandner S, Raio L. Soonographic Transvaginal bladder wall thickness: does measurement discriminate between urodynamic diagnoses? Neurourol Urodyn 2011; 30(3): 325-328.

(72) Robinson D, Abrams P, Cardozo L, Ellis-Jones J, Heath P, Wylie M. The Efficacy and Safety of PSD503 (phenylepherine 20% w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, two way cross over study. EJOGRB 2011. Accepted.